NEW YORK(GenomeWeb) – Diagnostics firm Abcodia said today that it has raised £5.25 million ($8 million) in funding to support launch of its ROCA ovarian cancer test.

The funding was co-led by Cambridge Innovation Capital and Scottish Equity Partners, which joined existing investors Albion Ventures and UCL Business. CIC Investment Director Robert Tansley and SEP Partner Jan Rutherford have been appointed to Abcodia's Board.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Jul
12
Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.